NeuroMetrix, Inc., a pioneering company in the field of neurotechnology, is headquartered in the United States and operates primarily across North America and Europe. Founded in 1996, NeuroMetrix has established itself as a leader in the development of innovative solutions for chronic pain management and diabetic neuropathy. The company’s flagship products, including the Quell® pain relief device and the DPNCheck® diagnostic tool, leverage advanced neurostimulation and diagnostic technologies, setting them apart in the healthcare landscape. NeuroMetrix is recognised for its commitment to improving patient outcomes through non-invasive therapies and has achieved significant milestones in clinical validation and market penetration. With a strong focus on research and development, NeuroMetrix continues to enhance its position in the neurotechnology industry, making strides in both product innovation and patient care.
How does NeuroMetrix, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
NeuroMetrix, Inc.'s score of 23 is lower than 66% of the industry. This can give you a sense of how well the company is doing compared to its peers.
NeuroMetrix, Inc., headquartered in the US, currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the company. This lack of data suggests that NeuroMetrix may not have established formal commitments to reduce its carbon footprint or engage in industry-standard climate initiatives at this time. As such, the company does not inherit emissions data from any parent or related organisations, nor does it participate in recognised frameworks like the Science Based Targets initiative (SBTi) or the Carbon Disclosure Project (CDP).
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
NeuroMetrix, Inc. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.